Epithelial apoptosis

BioEssays

Volumn 19, Issue 8, 1997, Pages 711-720

  Metcalfe, Anthony ^a   Streuli, Charles ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 0031214791     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/bies.950190812     Document Type: Review

References (90)

1. Saunders, J.W. (1966). Death in embryonic systems. Science 154, 604-612.
2. Hall, P.A., Coates, P.J., Ansari, B. and Hopwood, D. (1994). Regulation of cell number in the mammalian gastrointestinal-tract - the importance of apoptosis. J. Cell Sci. 107, 3569-3577.
3. Chinnaiyan, A.M. and Dixit, V.M. (1996). The cell-death machine. Curr. Biol. 6, 555-562.
4. White, E. (1996). Life, death, and the pursuit of apoptosis. Genes Dev. 10, 1-15.
5. Green, D.R. and Martin, S.J. (1995). The killer and the executioner: how apoptosis controls malignancy. Curr. Opin. Immunol. 7, 694-703.
6. Raff, M.C. (1992). Social controls on cell survival and cell death. Nature 356, 397-400.
7. Raff, M.C., Barres, B.A., Burne, J.F., Coles, H.S., Ishizaki, Y. and Jacobson, M. D. (1993). Programmed cell death and the control of cell survival: lessons from the nervous system. Science 262, 695-700.
8. Frisch, S.M. and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
9. Pullan, S. et al. (1996). Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J. Cell Sci. 109, 631-642.
10. Hermiston, M.L. and Gordon, J.I. (1995). In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J. Cell Biol. 129, 489-506.
11. Nagata, S. (1997). Apoptosis by Death Factor. Cell 88, 355-365.
12. Savill, J., Fadok, V., Henson, P. and Haslett, C. (1993). Phagocyte ecoqnition of cells undergoing apoptosis. Immunol. Today 14, 131-136.
13. Minshall, C., Arkins, S., Freund, G.G. and Kelley, K.W. (1996). Requirement for phosphatidylinositol 3′ kinase to protect hemopoietic progenitors against apoptosis depends upon the extracellular survival factor. J. Immunol. 156, 939-947.
14. Yao, R. and Cooper, G.M. (1995). Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267, 2003-2006.
15. Carlesso, N., Frank, D.A. and Griffin, J.D. (1996). Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl. J. Exp. Med. 183, 811-820.
16. Frisch, S.M., Vuori, K., Kelaita, D. and Sicks, S. (1996). A role for Jun-N-terminal kinase in anoikis; suppression by bcl-2 and crm A. J. Cell Biol. 135, 1377-1382.
17. Miyamoto, S. et al. (1995). Integrin function: molecular hierarchies of cytoskeletal and signaling molecules. J. Cell Biol. 131, 791-805.
18. Frisch, S.M., Vuori, K., Ruoslahti, E. and Chanhui, P.Y. (1996). Control of adhesion-dependent cell survival by focal adhesion kinase. J. Cell Biol. 134, 793-799.
19. Clark, E.A. and Brugge, J.S. (1995). Integrins and signal transduction pathways. Science 268, 233-239.
20. Farrow, S.N. and Brown, R. (1996). New members of the Bcl-2 family and their protein partners. Curr. Opin. Gen. Dev. 6, 45-49.
21. Blagosklonny, M.V., Schulte, T., Nguyen, P., Trepel, J. and Neckers, L.M. (1996). Taxol-induced apoptosis and phosphorylation of bcl-2 protein involves c-raf-1 and represents a novel c-raf-1 signal-transduction pathway. Cancer Res 56, 1851-1854.
22. Haldar, S. Chintapalli, J. and Croce, C.M. (1996). Taxol induces bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56, 1253-1255.
23. Miyashita, T. and Reed, U.C. (1995). Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80, 293-299.
24. Han, J., Sabbatini, P., Perez, D., Rao, L., Modha, D. and White, E. (1996). The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53 inducible and death promoting Bax protein. Genes Dev. 10, 461-477.
25. Yang, E. and Korsmeyer, S.J. (1996). Molecular Thanaptosis - A discourse on the Bcl-2 family and cell death. Blood 88, 386-401.
26. Veis, D., Sorenson, J.R., Shutter, J.R. and Korsmeyer, S.J. (1993). Bcl-2 deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 75, 229-240.
27. Knudson, C.M., Tung, K.S., Tourtellotte, W.G., Brown, G.A. and Korsmeyer, S.J. (1995). Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science 270, 96-99.
28. Driscoll, M. (1996). Cell death in C. elegans - molecular insights into mechanisms conserved between nematodes and mammals. Brain Path. 6, 411-425.
29. Cosulich, S.C., Green, S. and Clarke, P.R. (1996). Bcl-2 regulates activation of apoptotic proteases in a cell free system. Curr. Biol. 6, 997-1005.
30. Oltvai, Z.N. and Korsmeyer, S.J. (1994). Checkpoints of dueling dimers foil death wishes. Cell 79, 189-192.
31. Muchmore, S.W. et al. (1996). X-ray and NMR structure of human Bcl-x(I), an inhibitor of programmed cell-death Nature 381, 335-341.
32. Kroemer, G., Zamzami, N. and Susin, S.A. (1997). Mitochondrial control of apoptosis. Immunol. Today 18, 44-51.
33. Alnemri, E.S. et al. (1996). Human ICE/CED-3 protease nomenclature. Cell 87, 171.
34. Le Romancer, M., Cosulich, S., Jackson, P. and Clarke, P.R. (1996). Cleavage and inactivation of DNA dependent kinase catalytic subunit during apoptosis in Xenopus egg extracts. J. Cell Sci. 109, 3121-3127.
35. Brancolini, C., Benedetti, M. and Schneider, C. (1995). Microfilament reorganization during apoptosis; the role of Gas 2, a possible substrate for ICE-like proteases. EMBO J. 14, 5179-5190.
36. Skowronski, E.W., Kolesnik, R.N. and Green, D.R. (1996). Fas mediated apoptosis and sphingomyelinase signal transduction. The role of ceramide as a 2nd messenger for apoptosis. Cell Death Diff. 3, 171-176.
37. Litton, M.J. et al. (1996). Antibody-targeted superantigen therapy induces tumour-infiltrating lymphocytes, excessive cytokine production and apoptosis in human colon carcinoma. Eur. J. Immunol. 26, 1-9.
38. Potten, C.S. (1993). The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Can. Met. Revs 11, 179-195.
39. Merritt, A.J. et al. (1995). Differnetial expression of Bcl-2 in intestinal epithelia - correlation with attenuation of apoptosis in colonic crypts and the incidence of colonic neoplasia. J. Cell Sci. 108, 2261-2271.
40. Weil, et al. (1996). Constitutive expression of the machinery for programmed cell death. J. Cell Biol. 133, 1053-1059.
41. Barbareschi, M. et al. (1996). Bcl-2 and p53 expression in node-negative breast-carcinoma - a study with long-term follow-up. Human Path. 27, 1149-1155.
42. Eliopoulos, A.G. et al. (1995). The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 11, 1217-1228.
43. McDonnell, T. J. (1992). Expression of protoncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52, 6940-6944.
44. Verhaegh, M.E., Sanders, C.J., Arends, J.W. and Neumann, H.A. (1995). Expression of the apoptosis-suppressing protein Bcl-2 in non-melanoma skin cancer. Bd. J. Dermatol. 132, 740-744.
45. Tilly, J.L. (1996). Apoptosis and ovarian function. Rev. Reprod. 1, 162-172.
46. Tilly, J.L., Tilly, K.I., Kenton, M.L. and Johnson, A.L. (1995). Expression of members of the Bcl-2 gene family in the immature rat ovary: equine chorionic gonadotrophin-mediated inhibition of granulosa cell apoptosis is associated with decreased Bax and constitutive Bcl-2 and Bcl-xL messenger ribonucleic acid levels. Endocrinol. 136, 232-241.
47. Columbel, M.C. and Buttyan, R. (1995). Hormonal control of apoptosis: The rat prostate gland as a model system. In Cell Death. Methods in Cell Biology 46 (ed. L.M. Schwartz and B.A. Osbourne), pp. 369-385. Academic Press.
48. Berchem. G.J., Bosseler, M., Sugars, L.Y., Voeller, H.J., Zeitlin, S. and Gelmann, E.P. (1995). Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res. 55, 735-738.
49. Culig, Z. et al. (1996). Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone. Cancer Del. Prev. 20, 68-75
50. Potten, C.S. et al. (1988). The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Br. J. Cancer 58, 163-170.
51. Andres, A.C. Zuercher, G. Djonov, V. Flueck, M. and Ziemiecki, A. (1995). Protein-tyrosine kinase expression during the estrous-cycle and carcinogenesis of the mammary-gland. Int. J. Cancer 63, 288-296.
52. Walker, N.I. Bennet, R.E. and Kerr, J.F.R. (1989). Cell death by apoptosis during involution of the lactating breast in mice and rats. Am. J. Anat. 18, 19-32.
53. Strange, R., Li, F. Saurer, S. Burkhardt, A. and Friis, R.R. (1992). Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development 115, 49-58.
54. Streuli, C.H., Dive, C., Hickman, J.A., Farreley, N. and Metcalfe, A. (1997). Control of apoptosis in breast epithelium. Endocrine Related Cancer (in press).
55. Talhouk, R.S. Bissell, M.J. and Werb, Z. (1992). Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J. Cell Biol. 118, 1271-1282.
56. Lund, L.R. et al. (1996). Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 122 181-193.
57. Aggeler, J. et al. (1991). Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. J. Cell Sci. 99, 407-417.
58. Boudreau, N. Sympson, C.J. Werb, Z. and Bissell, M.J. (1995). Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267, 891-893.
59. Sheppard, D. (1996). Epithelial integrins. BioEssays 18, 655-660.
60. Clarke, A.S., Lotz, M.M., Chao, C. and Mercurio, A.M. (1995). Activation of the p21 pathway of growth arrest and apoptosis by the beta 4 integrin cytoplasmic domain. J. Biol. Chem. 270, 22673-22676.
61. Zhang, Z., Vuori, K., Reed, J.C. and Ruoslahti, E. (1995). The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc. Natl Acad. Sci. USA 92, 6161-6165.
62. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-1164.
63. Polakowska, R.R., Piacentini, M., Bartlett, R., Goldsmith, L.A. and Haake, A.R. (1994). Apoptosis in human skin development : morphogenesis, periderm and stem cells. Dev. Dyn. 199, 176-188.
64. Dowling, J., Yu, Q.-C. and Fuchs, E. (1996). β4 integrin is required for hemidesmosomal formation, cell adhesion and cell survival. J. Cell Biol. 134, 559-572.
65. Bates, R.C., Buret, A., Van Helden, D.F., Horton, M.A. and Burns, G.F. (1994). Apoptosis induced by inhibition of intercellular contact. J. Cell Biol. 125, 403-415.
66. Glucksmann, B. (1951). Cell deaths in normal vertebrate ontogeny. Biol. Rev. 26. 5-86.
67. Coucouvanis, E. and Martin, G.R. (1995). Signals for death and survival: a two step mechanism for cavitation in the vertebrate embryo. Cell 83, 279-287.
68. Longati, P., Albero, D. and Comoglio, P.M. (1996). Hepatocyte growth factor is a pleiotropic factor protecting epithelial cells from apotosis. Cell Death Diff. 3, 23-28.
69. Weldner, K.M., Di Cesare, S., Sachs, M., Brinkmann, V., Behrens, J. and Berchmeier, W. (1996). Interaction between Gab1 and the c-Met receptor tyrosine kinaseis responsible for epithelial morphogenesis. Nature 384, 173-176.
70. Medico, E. et al. (1996). The tyrosine kinase receptors Ron and Sea control scattering and morphogenesis of liver progenitor cells in vitro. Mol. Biol. Cell 7, 494-504.
71. Lu, P.J., Lu, Q.L., Rughetti, A. and Papadimitriou, J.T. (1995). bcl-2 overexpression inhibits cell death and promotes the morphogenesis, but not the tumorigenesis of human mammary epithelial cells. J. Cell Biol. 129, 1363-1378.
72. Bardelli, A. et al. (1996). HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death. EMBO J. 15, 6205-6212.
73. Allemand, I. et al. (1995). Compensatory apoptosis in response to SV40 large T antigen expression in liver. Oncogene 11, 2583-2590.
74. Cummings, M.C. (1996). Increased p53 mRNA expression in liver and kidney apoptosis. Biochem. Biophys. Acta 1315, 100-104.
75. Kren, B.T., Trembley, J.H., Krajewski, S., Behrens, T.W., Reed, J.C. and Steer, C.J. (1996). Modulation of apoptosis genes Bcl-2, Bcl-x and Bax during rat-liver regeneration. Cell Growth Diff. 7, 1633-1642.
76. Jacobson, M.D., Weil, M. and Raff, M.C. (1997). Programmed cell death in animal development. Cell 88, 347-354.
77. Takiya, S. et al. (1995). Role of transforming growth factor β1 on hepatic regeneration and apoptosis in liver diseases. J. Clin. Pathol. 48, 1093-1097.
78. Massague, J. (1990). The transforming growth factor-β family. Ann. Rev. Cell Biol. 6, 597-641.
79. Fausto, N. (1993). Hepatocyte apoptosis: is transforming growth factor the kiss of death? Hepatology 18, 1536.
80. Oberhammer, F.A. et al. (1992). Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. Proc. Natl Acad. Sci. USA 89, 5408-5412.
81. Williams, A.O., Knapton, A.D., Geiser, A., Letterio, J.J. and Roberts, A.B. (1996). The liver in Transforming growth factor beta-1 (TGF-Beta 1) null mutant mice. Ultrastruct. Pathol. 20, 477-490.
82. Ogasawara, J. et al. (1993). Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809.
83. Galle, P.R. et al. (1995). Involvement of CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
84. Mochizuki, K. et al. (1996). Fas antigen expression in liver - tissues of patients with chronic hepatitis B. J. Hepatol. 24, 1-7.
85. Harris, C.C. (1996). Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J. Natl Cancer Inst. 88, 1442-1455.
86. Levine, A. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
87. Harper, J.W., Adami, G.R., Wei, N., Keyomasi, K. and Elledge, S.J. (1993). The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75, 805-816.
88. Kastan, M.B., Oneykwere, O., Sidransky, D., Vogelstein, B. and Craig, R.W. (1991). Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311.
89. Ziegler, A. et al. (1994). Sunburn and p53 in the onset of skin-cancer. Nature 372, 773-776.
90. Schott, A.F., Apel, I.J., Nunez, G., Clarke, M.F. (1995). Bcl-xL protects cancer cells from p53 mediated apoptosis. Oncogene 11, 1389-1394.